Legal & General Group PLC Aadi Bioscience, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$6.84 - $8.56 $2,332 - $2,918	-341 Reduced 18.68%	1,484 $10,000
Q4 2022 Feb 14, 2023	BUY	$11.99 - $14.5 $3,201 - $3,871	267 Added 17.14%	1,825 $23,000
Q3 2022 Nov 14, 2022	SELL	$12.03 - $14.22 $14,640 - $17,305	-1,217 Reduced 43.86%	1,558 $22,000
Q2 2022 Aug 22, 2022	BUY	$11.57 - $17.92 $32,106 - $49,728	2,775 New	2,775 $34,000

12.6M

23.8K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $50.2M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.